SCHEMBL5370410

SCHEMBL5370410

Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC3 O15438 1/20 0.58
ABCC4 O15439 1/20 0.58
ABCB11 O95342 1/20 0.58
PGR P06401 1/20 0.58
ABCB1 P08183 1/20 0.58
CYP3A4 P08684 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
CHRM1 P11229 1/20 0.58
TBXA2R P21731 1/20 0.58
ADRA1A P35348 1/20 0.58
OPRM1 P35372 1/20 0.58
HTR2B P41595 1/20 0.58
KCNH2 Q12809 1/20 0.58
SCN5A Q14524 1/20 0.58
ABCG2 Q9UNQ0 1/20 0.58
KLK5 Q9Y337 2/20 0.50
ATM Q13315 1/20 0.49
KMT2A Q03164 1/20 0.47
PSEN1 P49768 3/20 0.45
PSEN2 P49810 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7385703 1.00 ABCC3 (0.58) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL5839261 0.94 ABCC3 (0.54) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL5369113 0.92 KLK5 (0.50) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL22305240 0.91 CYP3A4 (0.50) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL5373893 0.90 CYP3A4 (0.51) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL30261823 0.90 ABCC3 (0.65) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7152588 0.90 KLK5 (0.55) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL5368677 0.90 KLK5 (0.55) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL4961238 0.89 ADORA3 (0.64) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7391504 0.88 ABCC3 (0.47) ABCC3ABCC4ABCB11PGRABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1170289-A2 Retroviral protease inhibiting compounds Abbott Laboratories (US) 2002-01-09 EP claimed
WO-2020159343-A1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MIDDLE EAST RESPIRATORY SYNDROME 재단법인 경기도경제과학진흥원 2020-08-06 WO disclosed
US-7279582-B2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 2007-10-09 US disclosed
WO-2006090264-A1 A PROCESS FOR THE SYNTHESIS OF 2-AMINO-5-PROTECTED AMINO-3-HYDROXY-1, 6-DIPHENYLHEXANE OR A SALT THEREOF - AN INTERMEDIATE FOR ANTIVIRAL DRUGS RANBAXY LABORATORIES LIMITED (IN) 2006-08-31 WO disclosed
US-5914332-A NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS IN TREATING HIV AND AIDS ABBOTT LABORATORIES (US) 1999-06-22 US disclosed